Hormone Replacement Therapy Research Today is a free monthly online journal that collates and summarizes the latest research about Hormone Replacement Therapy, including details on hrt, menopause, natural hrt, effects, risks.

Volume 3 (2006), Issue 1 (January)

1. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study.
   Am J Ophthalmol, 141(1): 79-87. [Abstract] [Full-text]
2. Hormone replacement therapy, body mass index and asthma in perimenopausal women: a cross sectional survey.
   Thorax, 61(1): 34-40. [Abstract] [Full-text]
3. Scientific evidence changes prescribing practice--a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003.
   BJOG, 113(1): 15-20. [Abstract] [Full-text]
4. Hormone therapy and cardiovascular disease: a systematic review and meta-analysis.
   BJOG, 113(1): 5-14. [Abstract] [Full-text]
5. Discontinuation of postmenopausal hormone therapy.
   Am J Med, 118(12): 163-5. [Abstract] [Full-text]
6. The impact of risk status, preexisting morbidity, and polypharmacy on treatment decisions concerning menopausal symptoms.
   Am J Med, 118(12): 155-62. [Abstract] [Full-text]
7. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy?
   Am J Med, 118(12): 148-54. [Abstract] [Full-text]
8. Strategies and issues for managing menopause-related symptoms in diverse populations: ethnic and racial diversity.
   Am J Med, 118(12): 142-7. [Abstract] [Full-text]
9. Bilateral oophorectomy and premature menopause.
   Am J Med, 118(12): 131-5. [Abstract] [Full-text]
10. Therapeutic effects of progestins, androgens, and tibolone for menopausal symptoms.
    Am J Med, 118(12): 88-92. [Abstract] [Full-text]
11. Estrogen with and without progestin: benefits and risks of short-term use.
    Am J Med, 118(12): 79-87. [Abstract] [Full-text]
12. Vasomotor symptom relief versus unwanted effects: role of estrogen dosage.
    Am J Med, 118(12): 74-8. [Abstract] [Full-text]
13. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
    Am J Med, 118(12): 64-73. [Abstract] [Full-text]
14. Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo-controlled study.
    J Intern Med, 259(2): 199-208. [Abstract] [Full-text]
15. Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal women.
    Arterioscler Thromb Vasc Biol, 26(2): 385-91. [Abstract] [Full-text]
16. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.
    J Clin Oncol, 24(4): 587-92. [Abstract] [Full-text]

© 2004-2008 Hormone Replacement Therapy Research Today. All Rights Reserved.